Authored By: Sarah
15 Jul 2024

 Cementless Total Knee Arthroplasty Market Size to grow by USD 4602 million between 2024-2028

According to a research report “ Cementless Total Knee Arthroplasty Market” by Product (Fixed-bearing, Mobile-bearing) End-user (Hospitals, Orthopedic clinics, Ambulatory surgical centers) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 4602 million, at a CAGR of  30.08% during the forecast period. In the healthcare industry, arthritis, a condition characterized by inflammation, pain, and joint stiffness, affects a significant number of adults, particularly in the US. According to the Centers for Disease Control and Prevention (CDC), the prevalence of arthritis is projected to rise, with an estimated 54 million adults anticipated to be diagnosed in the country. Osteoarthritis, a common form of arthritis, primarily affects the knees, leading to cartilage degeneration and joint dysfunction. To address this issue, the cementless total knee arthroplasty market has emerged as a viable solution, offering a surgical intervention to restore joint function and alleviate pain for those suffering from advanced stages of osteoarthritis. This market is poised for growth due to the increasing prevalence of arthritis and the demand for minimally invasive, durable, and functional replacement options.

Browse market data tables, figures, and in-depth TOC on “Cementless Total Knee Arthroplasty Market” by Product (Fixed-bearing, Mobile-bearing) End-user (Hospitals, Orthopedic clinics, Ambulatory surgical centers) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028. Download Free Sample


By Product, the Fixed-bearing segment is projected to dominate the market size in 2024

The cementless total knee arthroplasty market experiences significant growth due to the substantial demand from large hospitals and hospital groups. These institutions, including multi-specialty hospitals, are major end-users, offering both inpatient and outpatient cardiac services. With capacities of up to 500 beds, they procure medical devices and consumables in substantial quantities. Engaging closely with suppliers, reimbursement authorities, and government organizations, these hospitals prioritize the acquisition of advanced therapeutic devices, such as cementless total knee implants, to enhance patient care and maintain favorable reimbursement arrangements.

By End-user, Hospitals  segment is expected to hold the largest market size for the year 2024

In the realm of cementless Total Knee Arthroplasty (TKA), fixed-bearing knee implants represent a cost-effective solution due to their simplified design. These implants feature a permanently affixed polyethylene spacer between the tibial and femoral components, eliminating the need for cement. Despite concerns over polyethylene wear, advancements in wear-resistant materials and improved component locking mechanisms are mitigating this challenge. The fixed-bearing platform's simplicity reduces surgical complexity and offers a viable alternative to more complex mobile-bearing/rotating-platform implants.

North America is forecasted to hold the largest market size by region in 2024

The cementless total knee arthroplasty market represents a significant growth opportunity for medical device manufacturers. This segment of the knee replacement market is gaining traction due to its advantages, including improved bone ingrowth, reduced risk of complications associated with cement, and enhanced patient mobility. Market trends indicate a shift towards cementless solutions, making it a lucrative business proposition for companies focusing on orthopedic innovations.

The Cementless Total Knee Arthroplasty Market growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:

  • Aesculap Implants Systems LLC
  • Allegra Orthopaedics Ltd.
  • B.Braun SE
  • Beijing Chunlizhengda Medical Instruments Co. Ltd.
  • C2F Implants
  • Conformis Inc.
  • Corin Group Plc
  • DJO Global Inc.
  • Euromed Implants GmbH
  • Exactech Inc.
  • Johnson and Johnson Services Inc.
  • Medacta International SA
  • MicroPort Scientific Corp.
  • Smith and Nephew plc
  • Stryker Corp.
  • Symbios Orthopedie SA
  • United Orthopedic Corp.
  • Waldemar Link GmbH and Co. KG
  • Zimmer Biomet Holdings Inc.

For insights on company offerings- Request a sample report!

Research Analysis Overview

Title: Cementless Total Knee Arthroplasty: Advancements and Market Trends The burden of disease from knee pain due to osteoarthritis (OA), tendon diseases, obesity, and sports-related injuries continues to rise, leading to an increase in knee replacement surgeries. Traditional cemented knee arthroplasty has been the gold standard, but cementless total knee arthroplasty (TKA) is gaining popularity due to its benefits, including improved implant stability, osseointegration, and longer-term outcomes. Clinical studies show that cementless TKA offers better implant fixation and bone growth through osseointegration. The absence of bone cement reduces the risk of complications such as infection, allergic reactions, and loosening. However, cementless TKA also presents challenges, including the need for precise implant alignment and surgical techniques. The global cementless TKA market is expected to grow due to the increasing elderly population, rising prevalence of knee OA, and advancements in implant design and materials, such as ceramic and metal alloys. The Centers for Disease Control and Prevention (CDC) reports that over 700,000 knee replacement surgeries are performed annually in the US alone. Despite the advantages, cementless TKA still faces challenges, including high costs and potential complications related to implant stability and fixation materials. In summary, cementless TKA offers several benefits over traditional cemented TKA, but it also presents challenges. The market for cementless TKA is expected to grow due to demographic trends and technological advancements, but cost and complications remain concerns. Continued research and innovation in implant design, materials, and surgical methods will be essential to optimize the benefits of cementless TKA and improve patient outcomes.

Market Research Overview

The Cementless Total Knee Arthroplasty (TKA) market is a significant segment of the healthcare industry, driven by the increasing prevalence of knee osteoarthritis, an aging population, and a growing awareness of the benefits of cementless knee replacements. Trust in the safety and efficacy of cementless TKAs is high due to ongoing innovation and stringent regulatory oversight. Regulatory bodies, such as the FDA and CE Mark, ensure the safety and quality of these medical devices. Surgeon preferences and patient awareness play a crucial role in the market's growth. Lifestyle factors, demographic changes, and the burden of disease, including disability and knee pain, also contribute to the demand for cementless TKAs. However, cost considerations, including copayments, deductibles, and insurance coverage, can impact patient access to these surgical procedures. New technology, such as DePuy Synthes ATTUNE and Persona OsseoTi, and implant design innovations, including alloys, ceramics, fixed bearings, and mobile bearings, are driving advancements in cementless TKAs. Complications, such as implant stability and prosthesis fixation, are being addressed through the use of new materials and implant designs. Navigating complex reimbursement policies and cost constraints, including Medicaid and Medicare, require a deep understanding of the regulatory framework and insurance coverage. The prevalence of osteoarthritis, obesity, elderly population, tendon diseases, and sports-related injuries continue to fuel the demand for cementless TKAs. The long-term outcomes of cementless TKAs, including bone growth and osseointegration, are being studied through clinical studies to further establish their benefits.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200

Read News Read Less
Interested in this report?
Get your sample now!